PPARD and metabolic dysfunction-associated steatotic liver disease: Therefore, we sought to test the hypothesis that PPARδ agonism may carry a risk of promoting hepatic fatty accumulation similar to Nonalcoholic Fatty Liver Disease (NAFLD).